News
We recently published 8 Stocks That Jim Cramer Recently Talked About. Novartis AG (NYSE:NVS) is one of the stocks Jim Cramer recently discussed. Novartis AG (NYSE:NVS) is a Swiss pharmaceutical ...
The pharmaceutical company raised its full-year profit guidance as ongoing demand for key drugs fueled growth in ...
While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...
Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
3d
Investor's Business Daily on MSNNovartis Sacrifices A Breakout As One Of Its Bread-And-Butter Drugs MissesNovartis stock fell early Thursday after the drugmaker reported light sales of Cosentyx, one of its biggest moneymakers.
Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong revenue growth from products ...
A U.S. federal judge rejected Swiss drugmaker Novartis' request for a preliminary injunction to stop MSN Pharmaceuticals from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results